{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:08:53Z","timestamp":1787501333944,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Despite the well-recognized association between malignancy and myositis, definite data indicating the best strategy for diagnosing cancer in myositis patients is lacking. In this article, we review the data on cancer screening in patients with myositis, and propose an algorithm for this purpose based on recently published data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Evidence has recently emerged supporting blind screening in patients with certain myositis phenotypes. In addition to the clinical examination, imaging techniques such as PET\/computed tomography scanning and whole-body MRI, and determination of the autoantibody profile beyond anti-TIF1\u03b3 antibody, the well known cancer biomarker in dermatomyositis, will help the clinician face this complex clinical situation. Molecules related to the checkpoint inhibitor pathway, specifically soluble programmed death 1, may also have a role in the diagnostic work-up of cancer in myositis. In the future, blood tests analysing circulating DNA will certainly help in detecting patients with cancer-associated myositis (CAM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>A step forward has been achieved in the pathway to establish optimal cancer screening for myositis patients. International consensus guidelines for an effective diagnostic work-up of CAM are in progress and will be of paramount importance to improving the outcome in these patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000000535","type":"journal-article","created":{"date-parts":[[2018,6,30]],"date-time":"2018-06-30T01:51:06Z","timestamp":1530323466000},"page":"630-636","source":"Crossref","is-referenced-by-count":45,"title":["The diagnostic work-up of cancer-associated myositis"],"prefix":"10.1097","volume":"30","author":[{"given":"Albert","family":"Selva-O\u2019Callaghan","sequence":"first","affiliation":[{"name":"Systemic Autoimmune Diseases Unit, Medicine Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Martinez-G\u00f3mez","sequence":"additional","affiliation":[{"name":"Preventive Medicine and Epidemiology, Vall d\u2019Hebron General Hospital, Universitat Aut\u00f2noma de Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Trallero-Aragu\u00e1s","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Vall d\u2019Hebron General Hospital, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iago","family":"Pinal-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Muscle Diseases Unit, NIAMS, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230901","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1203475416665601","article-title":"Risk of malignancy in dermatomyositis and polymyositis","volume":"21","author":"Qiang","year":"2017","journal-title":"J Cutan Med Surg"},{"key":"R2-20230901","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R3-20230901","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/art.33379","article-title":"Usefulness of antip155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis","volume":"64","author":"Trallero-Aragu\u00e1s","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R4-20230901","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/acr.23188","article-title":"Antinuclear matrix protein 2 autoantibodies and edema, muscle disease, and malignancy risk in dermatomyositis patients","volume":"69","author":"Albayda","year":"2017","journal-title":"Arthritis Care Res"},{"key":"R5-20230901","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/brain\/aww024","article-title":"Association of inclusion body myositis with T cell large granular lymphocytic leukaemia","volume":"139","author":"Greenberg","year":"2016","journal-title":"Brain"},{"key":"R6-20230901","doi-asserted-by":"crossref","first-page":"700","DOI":"10.12659\/AJCR.903566","article-title":"Inclusion body myositis: a case presenting with respiratory failure and autopsy findings leading to the hypothesis of a paraneoplastic cause","volume":"18","author":"Dardis","year":"2017","journal-title":"Am J Case Rep"},{"key":"R7-20230901","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/aww054","article-title":"High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody","volume":"139","author":"Allenbach","year":"2016","journal-title":"Brain"},{"key":"R8-20230901","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1212\/NXI.0000000000000290","article-title":"Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy","volume":"3","author":"Kadoya","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R9-20230901","first-page":"787","article-title":"More severe disease and slower recovery in younger patients with anti3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy","volume":"56","author":"Tiniakou","year":"2017","journal-title":"Rheumatology"},{"key":"R10-20230901","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13023-015-0277-y","article-title":"Inflammatory myopathy with antisignal recognition particle antibodies: case series of 100 patients","volume":"10","author":"Suzuki","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"R11-20230901","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/acr.22920","article-title":"Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle","volume":"69","author":"Pinal-Fernandez","year":"2017","journal-title":"Arthritis Care Res"},{"key":"R12-20230901","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/rheumatology\/kex021","article-title":"A longitudinal cohort study of the antisynthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies","volume":"56","author":"Pinal-Fernandez","year":"2017","journal-title":"Rheumatology"},{"key":"R13-20230901","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1684\/ejd.2016.2890","article-title":"A case of antisynthetase syndrome with elevated serum CA19-9 associated with interstitial lung disease","volume":"27","author":"Minami","year":"2017","journal-title":"Eur J Dermatol"},{"key":"R14-20230901","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/acr.23325","article-title":"Association of anti-transcription intermediary factor 1\u03b3 antibodies with paraneoplastic rheumatic syndromes other than dermatomyositis","volume":"70","author":"Venalis","year":"2018","journal-title":"Arthritis Care Res"},{"key":"R15-20230901","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/rheumatology\/kex413","article-title":"Tumour TIF1 mutations and loss of heterozygosity related to cancer-associated myositis","volume":"57","author":"Pinal-Fernandez","year":"2018","journal-title":"Rheumatology"},{"key":"R16-20230901","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1126\/science.1246886","article-title":"Association of the autoimmune disease scleroderma with an immunologic response to cancer","volume":"343","author":"Joseph","year":"2014","journal-title":"Science"},{"key":"R17-20230901","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/ced.13180","article-title":"Expression of the autoantigen TRIM33\/TIF1\u03b3 in skin and muscle of patients with dermatomyositis is upregulated, together with markers of cellular stress","volume":"42","author":"Scholtissek","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"R18-20230901","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s13075-017-1469-8","article-title":"Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study","volume":"19","author":"Yang","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"R19-20230901","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3899\/jrheum.170544","article-title":"Increased levels of soluble programmed death ligand 1 associate with malignancy in patients with dermatomyositis","volume":"45","author":"Chen","year":"2018","journal-title":"J Rheumatol"},{"key":"R20-20230901","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12967-017-1136-5","article-title":"Pyruvate kinase M2 and the mitochondrial ATPase inhibitory factor 1 provide novel biomarkers of dermatomyositis: a metabolic link to oncogenesis","volume":"15","author":"Santacatterina","year":"2017","journal-title":"J Transl Med"},{"key":"R21-20230901","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multianalyte blood test","volume":"359","author":"Cohen","year":"2018","journal-title":"Science"},{"key":"R22-20230901","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.amjmed.2009.11.012","article-title":"Conventional cancer screening versus PET\/CT in dermatomyositis\/polymyositis","volume":"123","author":"Selva-O\u2019Callaghan","year":"2010","journal-title":"Am J Med"},{"key":"R23-20230901","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1007\/s10067-017-3794-3","article-title":"Multiple values of (18)F-FDG PET\/CT in idiopathic inflammatory myopathy","volume":"36","author":"Li","year":"2017","journal-title":"Clin Rheumatol"},{"key":"R24-20230901","first-page":"5023","article-title":"[(18)F]Fluorodeoxyglucose positron emission tomography\/computed tomography for diagnosing polymyositis\/dermatomyositis","volume":"15","author":"Sun","year":"2018","journal-title":"Exp Ther Med"},{"key":"R25-20230901","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/RLU.0000000000001727","article-title":"Intense muscle activity due to polymyositis incidentally detected in a patient evaluated for possible malignancy by FDG PET\/CT imaging","volume":"42","author":"Bai","year":"2017","journal-title":"Clin Nucl Med"},{"key":"R26-20230901","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/rheumatology\/ket112","article-title":"[18F]FDG uptake in proximal muscles assessed by PET\/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis\/dermatomyositis","volume":"52","author":"Tanaka","year":"2013","journal-title":"Rheumatology"},{"key":"R27-20230901","doi-asserted-by":"crossref","first-page":"e0181069","DOI":"10.1371\/journal.pone.0181069","article-title":"An efficacy analysis of whole-body magnetic resonance imaging in the diagnosis and follow-up of polymyositis and dermatomyositis","volume":"12","author":"Huang","year":"2017","journal-title":"PLoS One"},{"key":"R28-20230901","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1212\/WNL.0000000000003337","article-title":"Evaluation of dysphagia by novel real-time MRI","volume":"87","author":"Olthoff","year":"2016","journal-title":"Neurology"},{"key":"R29-20230901","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/imj.13556","article-title":"Malignancy screening in autoimmune myositis among Australian rheumatologists","volume":"47","author":"Dutton","year":"2017","journal-title":"Intern Med J"},{"key":"R30-20230901","doi-asserted-by":"crossref","first-page":"e9639","DOI":"10.1097\/MD.0000000000009639","article-title":"Evidence supports blind screening for internal malignancy in dermatomyositis: data from 2 large US dermatology cohorts","volume":"97","author":"Leatham","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R31-20230901","doi-asserted-by":"crossref","first-page":"e429","DOI":"10.3747\/co.24.3696","article-title":"Breast cancer and dermatomyositis: a case study and literature review","volume":"24","author":"Hendren","year":"2017","journal-title":"Curr Oncol"},{"key":"R32-20230901","article-title":"Dermatomyositis and colorectal cancer: a systematic review","author":"Gkegkes","year":"2017","journal-title":"Ir J Med Sci"},{"key":"R33-20230901","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jns.2016.08.060","article-title":"Inflammatory myopathies and lymphoma","volume":"369","author":"St\u00fcbgen","year":"2016","journal-title":"J Neurol Sci"},{"key":"R34-20230901","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12016-015-8511-x","article-title":"Idiopathic inflammatory myopathies and malignancy: a comprehensive review","volume":"52","author":"Tiniakou","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"R35-20230901","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40985-018-0080-0","article-title":"Cancer screening recommendations: an international comparison of high income countries","volume":"39","author":"Ebell","year":"2018","journal-title":"Public Health Rev"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201811000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T21:17:35Z","timestamp":1693516655000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201811000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000535","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}